Keyphrases
Hepatitis A
100%
Genotype
81%
Hepatitis A Virus
70%
High-risk Human Papillomavirus (HR-HPV)
62%
HPV16
57%
Hepatitis E Virus
48%
Men Who Have Sex with Men
46%
Hepatitis C Virus Infection
46%
SARS-CoV-2 Infection
43%
COVID-19
43%
Hepatitis C Virus
42%
Neutralizing Antibodies
42%
Pseudovirus
41%
Capsid Protein
40%
Major Capsid Protein
38%
Wales
38%
Risk Factors
36%
Dried Blood Spots
35%
Hepatitis E
34%
Secondary School
34%
People Who Inject Drugs
33%
Cross-neutralizing Antibody
32%
Vaccination
32%
Virus
32%
Human Papillomavirus Vaccine
31%
Antigenicity
30%
HPV18
30%
Virus-like
28%
Northern Ireland
27%
Europe
26%
Primary School
26%
Infection Rate
26%
Immunization
25%
United Kingdom
25%
Virus Transmission
24%
SARS-CoV-2 Antibodies
24%
Type-specific
23%
Hepatitis B Virus
23%
Cervarix
23%
Oral Fluid
23%
Vaccine Antibodies
22%
Vaccine Response
22%
HPV58
22%
HPV31
22%
Blood Donors
21%
Antibody Response
21%
Capsid
21%
Hepatitis A Infection
21%
Confirmed Cases
20%
Cervical Disease
20%
HPV-45
20%
Epidemiology
20%
Virus RNA
19%
Household Transmission
19%
Anti-spike Antibody
19%
Seropositivity
19%
European Economic Area
19%
European Union
19%
Hepatitis E Virus Infection
18%
Secondary School Students
18%
School Staff
18%
HPV33
18%
Viral Load
18%
Human Papillomavirus Genotypes
18%
Hepatitis C
18%
Cross-protection
17%
Injecting Drug Users
17%
Persistent Infection
17%
Unlinked
16%
Seroprevalence
16%
Molecular Epidemiology
15%
Minor Capsid Protein
15%
Protein Variants
15%
Antibody Persistence
15%
Rapid Test
15%
Gardasil
15%
Disease Stage
15%
Non-vaccine Types
15%
Adjusted Odds Ratio
15%
Whole Genome Sequencing
15%
Virus Strains
14%
Lineage-specific
14%
Genotype 3
14%
Antibody Prevalence
14%
Infectivity
14%
Confidence Interval
14%
Natural Infection
14%
Cross-neutralization
13%
Travellers
13%
Human Papillomavirus Types
13%
Spike Protein
12%
Hepatitis C Virus RNA
12%
L1 Protein
12%
Viremia
12%
Oncogenic Human Papillomavirus
12%
Quantitative PCR
12%
Oral Fluid Testing
11%
Primary School Students
11%
Vaccination Protocols
11%
Seasonal Coronavirus
11%
Immunology and Microbiology
Wart Virus
70%
Capsid
69%
Neutralizing Antibody
62%
Hepatitis A
62%
Lineages
55%
Hepatitis A Virus
54%
Prevalence
54%
Human Papillomavirus Type 16
49%
Severe Acute Respiratory Syndrome Coronavirus 2
49%
Virus
43%
Cervarix
37%
Hepatitis C Virus
34%
Neutralization
33%
Human Papillomavirus Type 18
31%
Human Papillomavirus Type 45
31%
Hepatitis E Virus
31%
Hepatitis C
31%
Antigenicity
29%
Antibody Response
26%
Virus-Like Particle
25%
Spike
23%
Human Papillomavirus Type 58
22%
Human Papillomavirus Type 31
20%
Seroprevalence
19%
Viral Load
19%
Human Papillomavirus Type 33
18%
Human Papillomavirus Type 52
17%
RNA Virus
15%
Monoclonal Antibody
15%
HPV Vaccine
15%
Hepatitis B Virus
15%
Antibody Titer
14%
Seropositivity
13%
Cross Protection
13%
ELISA
12%
Serotype
12%
Hepatitis B
12%
Virus Strain
12%
Immune Response
11%
Seroconversion
11%
Blood Plasma
11%
Epitope
10%
L1 (Protein)
10%
Hepatitis B Antigen
10%
HBsAg
10%
Immunogenicity
10%
Cladistics
9%
Antibody Specificity
9%
Infection Rate
8%
Receptor Binding
8%
Humoral Immunity
8%
Hepatitis E
8%
Shigella
8%
Virus Nucleocapsid
7%
Virus Vaccine
7%
Human Papillomavirus Type 51
7%
Chlamydiae
7%
Human Herpesvirus 8
7%
Virus Antigen
7%
Wild Type
7%
Mouth
7%
Methylation
7%
Omicron Coronavirus Variant
7%
Protein Motif
7%
Infectious Agent
7%
COVID-19
7%
Hepatitis C Virus Genotype 4
7%
Molecular Epidemiology
7%
Blood Component
7%
Whole Genome Sequencing
7%
Allograft
7%
Titer
6%
Enteroaggregative Escherichia Coli
6%
Virus Transmission
6%
Virus Genome
6%
Antiserum
6%
Immunoglobulin M
6%
Campylobacter
5%
Cross Reacting Antibody
5%
Human Immunodeficiency Virus
5%
Immunoassay
5%
High Risk Population
5%